Quantifying cardiometabolic risk using modifiable non-self-reported risk factors

American Journal of Preventive Medicine

Volumn 47, Issue 2, 2014, Pages 131-140

  Marino, Miguel ^a   Li, Yi ^b   Pencina, Michael J ^c   D'Agostino, Ralph B ^d   Berkman, Lisa F ^f   Buxton, Orfeu M ^e,g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d BOSTON UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLASSIFICATION ALGORITHM; COMPARATIVE STUDY; CONTROLLED STUDY; D' AGOSTINO RISK SCORE; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PREDICTIVE VALUE; PROGENY; RISK ASSESSMENT; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; VALIDATION STUDY; ALGORITHM; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COHORT ANALYSIS; METABOLIC DISEASES; METABOLISM; MIDDLE AGED; PRIMARY PREVENTION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; ALGORITHMS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 84904644369     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.03.006     Document Type: Article

References (56)

1. W. Rosamond, K. Flegal, and K. Furie et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 4 2008 e25 e146
2. R.H. Eckel, J.M. Jakicic, and J.D. Ard et al. AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol S0735-1097 13 2013 06029-4
3. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 18 1998 1837 1847
4. J.D. Berry, A. Dyer, and X. Cai et al. Lifetime risks of cardiovascular disease N Engl J Med 366 4 2012 321 329
5. D.M. Lloyd-Jones, E.P. Leip, and M.G. Larson et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 6 2006 791 798
6. R.B. D'Agostino Sr, R.S. Vasan, and M.J. Pencina et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 6 2008 743 753
7. M.J. Pencina, R.B. D'Agostino Sr, M.G. Larson, J.M. Massaro, and R.S. Vasan Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study Circulation 119 24 2009 3078 3084
8. W. de Ruijter, R.G. Westendorp, and W.J. Assendelft et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ 338 2009 a3083
9. A.K. Marma, and D.M. Lloyd-Jones Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile Circulation 120 5 2009 384 390
10. D.M. Lloyd-Jones Cardiovascular risk prediction: basic concepts, current status, and future directions Circulation 121 15 2010 1768 1777
11. S.W. Keith, K.R. Fontaine, N.M. Pajewski, T. Mehta, and D.B. Allison Use of self-reported height and weight biases the body mass index-mortality association Int J Obes (Lond) 35 3 2011 401 408
12. G. Danaei, M.M. Finucane, and Y. Lu et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 9785 2011 31 40
13. G. Danaei, A.B. Friedman, S. Oza, C.J. Murray, and M. Ezzati Diabetes prevalence and diagnosis in U.S. states: analysis of health surveys Popul Health Metr 7 2009 16
14. J.K. Pai, L.E. Cahill, F.B. Hu, K.M. Rexrode, J.E. Manson, and E.B. Rimm Hemoglobin A1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women J Am Heart Assoc 2 2 2013 e000077
15. G. Hu, Q. Qiao, J. Tuomilehto, M. Eliasson, E.J. Feskens, and K. Pyorala Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies Diabetologia 47 7 2004 1245 1256
16. S. Kaptoge, E. Di Angelantonio, and G. Lowe et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 9709 2010 132 140
17. S. Kapur, and D. Zava Cardiometabolic risk factors assessed by a finger stick dried blood spot method J Diabetes Sci Technol 2 2 2008 236 241
18. R. Lakshmy Analysis of the use of dried blood spot measurements in disease screening J Diabetes Sci Technol 2 2 2008 242 243
19. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 35 1S 2012 S64 S71
20. WHO. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Geneva: WHO. Report No.: WHO/NMH/CHP/CPM/11.1.
21. G. Rose, K. Katy-Tee, and M. Marmot The strategy of preventive medicine 2008 Oxford University Press, U.S. Oxford
22. M. Feinleib, W.B. Kannel, R.J. Garrison, P.M. McNamara, and W.P. Castelli The Framingham Offspring Study. Design and preliminary data Prev Med 4 4 1975 518 525
23. W.B. Kannel, M. Feinleib, P.M. McNamara, R.J. Garrison, and W.P. Castelli An investigation of coronary heart disease in families. The Framingham Offspring Study Am J Epidemiol 110 3 1979 281 290
24. W.B. Kannel, R.B. D'Agostino, H. Silbershatz, A.J. Belanger, P.W. Wilson, and D. Levy Profile for estimating risk of heart failure Arch Intern Med 159 11 1999 1197 1204
25. L.A. Cupples, and R.B. D'Agostino Section 34: some risk factors related to annual incidence of cardiovascular disease and death in pooled repeated biennial measurements W.B. Kannel, P.A. Wolf, R.J. Garrison, Framingham Heart Study: 30-year follow-up 1987 USDHHS Bethesda MD
26. M.K. Rutter, J.B. Meigs, L.M. Sullivan, R.B. D'Agostino Sr, and P.W. Wilson C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study Circulation 110 4 2004 380 385
27. D.M. Nathan, D.E. Singer, K. Hurxthal, and J.D. Goodson The clinical information value of the glycosylated hemoglobin assay N Engl J Med 310 6 1984 341 346
28. J.B. Meigs, D.M. Nathan, L.A. Cupples, P.W. Wilson, and D.E. Singer Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study J Clin Epidemiol 49 4 1996 411 417
29. J.B. Meigs, D.M. Nathan, P.W. Wilson, L.A. Cupples, and D.E. Singer Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study Ann Intern Med 128 7 1998 524 533
30. D.M. Lloyd-Jones, J.C. Evans, M.G. Larson, and D. Levy Treatment and control of hypertension in the community: a prospective analysis Hypertension 40 5 2002 640 646
31. D.R. Cox Regression models and life tables J Roy Statist Soc Ser B 34 2 1972 187 220
32. P.M. Grambsch, T.M. Therneau, and T.R. Fleming Diagnostic plots to reveal functional form for covariates in multiplicative intensity models Biometrics 51 4 1995 1469 1482
33. P.M. Grambsch, and T.M. Therneau Proportional hazard tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
34. F.E. Harrell Regression modeling strategies 2001 Springer New York
35. M.J. Pencina, and R.B. D'Agostino Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 13 2004 2109 2123
36. T. Hastie, R. Tibshirani, and J. Friedman The elements of statistical learning 2003 Springer New York
37. P.J. Heagerty, and Y. Zheng Survival model predictive accuracy and ROC curves Biometrics 61 1 2005 92 105
38. B. Efron, and G. Gong A leisurely look at the bootstrap, the jackknife and cross-validation Am Stat 37 1 1983 36 48
39. P.J. Verweij, and H.C. Van Houwelingen Cross-validation in survival analysis Stat Med 12 24 1993 2305 2314
40. F.E. Harrell Jr, K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 4 1996 361 387
41. R. D'Agostino, and B.H. Nam Evaluation of the performance of survival analysis models: discrimination and calibration measures N. Balakrishnan, C.R. Rao, Handbook of statistics 2004 Elsevier Amsterdam
42. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr, and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2 2008 157 172 discussion 207-12
43. M.T. Cooney, A. Dudina, R. D'Agostino, and I.M. Graham Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 122 3 2010 300 310
44. G. Rose Strategy of prevention: lessons from cardiovascular disease BMJ 282 6279 1981 1847 1851
45. T. Terry, K. Raravikar, N. Chokrungvaranon, and P.D. Reaven Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT Curr Cardiol Rep 14 1 2012 79 88
46. American Diabetes Association Standards of medical care in diabetes - 2013 Diabetes Care 36 1S 2013 S11 S66
47. E. Selvin, M.W. Steffes, and H. Zhu et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 9 2010 800 811
48. American Diabetes Association Summary of revisions for the 2013 clinical practice recommendations Diabetes Care 36 1S 2013 S3
49. N.R. Cook, N.P. Paynter, and C.B. Eaton et al. Comparison of the Framingham and Reynolds risk scores for global cardiovascular risk prediction in the multiethnic women's health initiative Circulation 125 14 2012 1748 1756 S1-S11
50. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 20 2002 1557 1565
51. R. Detrano, A.D. Guerci, and J.J. Carr et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 358 13 2008 1336 1345
52. M.S. Pepe, H. Janes, G. Longton, W. Leisenring, and P. Newcomb Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker Am J Epidemiol 159 9 2004 882 890
53. N.S. Rost, P.A. Wolf, and C.S. Kase et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study Stroke 32 11 2001 2575 2579
54. P.W. Wilson, B.H. Nam, M. Pencina, R.B. D'Agostino Sr, E.J. Benjamin, and C.J. O'Donnell C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study Arch Intern Med 165 21 2005 2473 2478
55. P.W. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr, and C.J. O'Donnell C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circulation Circ Cardiovasc Qual Outcomes 1 2 2008 92 97
56. R.B. D'Agostino Sr, S. Grundy, L.M. Sullivan, and P. Wilson Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA 286 2 2001 180 187